Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Metadata
Title
A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model
Authors
Babak Rashidi
Meng Yang
Ping Jiang
Eugene Baranov
Zili An
Xiaoen Wang
A.R. Moossa
R.M. Hoffman
Publication date
01-01-2000
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 1/2000
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1026596131504

Other articles of this Issue 1/2000

Clinical & Experimental Metastasis 1/2000 Go to the issue

OriginalPaper

Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor

OriginalPaper

Social isolation stress augments angiogenesis induced by colon 26-L5 carcinoma cells in mice

OriginalPaper

CD44 and β1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins

OriginalPaper

Isolation and characterization of cell lines with reduced urokinase binding

OriginalPaper

Interaction of tumor cells with vascular endothelia: Role of platelet-activating factor

OriginalPaper

Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits